About the Company
cyclacel limited is a pharmaceuticals company located in 46-48 e smithfield, london, united kingdom.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CYCC News
Cyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Credit
The R&D tax credit has been an important source of non-dilutive capital supporting Cyclacel’s programs. We appreciate this governmental support as we evaluate potential precision medicine approaches ...
Earnings week ahead: FedEx, Nike, XPeng, Tencent, General Mills and more
StoneCo (STNE), a provider of financial technology and software solutions, is scheduled to report its Q4 earnings after ...
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce ...
Bio-Path files to sell 1.15M shares of common stock, warrants
Bio-Path Holdings ( NASDAQ: BPTH) filed a prospectus related to the offer and sell of 1,152,073 shares of its common stock, warrants.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call Transcript March 13, 2024 scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, ...
Before Buying Cyclo Therapeutics Inc (NASDAQ: CYTH) Stock, Read This First
Cyclo Therapeutics Inc (NASDAQ:CYTH) shares, rose in value, without any change to the previous day’s close as strong demand from buyers drove the stock to $1.62. Actively observing the price movement ...
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call Transcript March 12, 2024 MaxCyte, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.1. MaxCyte, Inc. isn't one of the 30 most popular stocks among ...
Loading the latest forecasts...